Abiopharma

🔍 Rodeheaver Carissa Lynn (Director)

Company: FIRST UNITED CORP/MD/ (FUNC)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 44 shares of Common Stock at $37.7 per share (Direct)
  Date: 2026-05-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 47,776.67 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 123 shares of Common Stock at $38.1 per share (Direct)
  Date: 2026-05-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 47,899.81 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By spouse as UTMA custodian for son | shares_owned_after: 86.84 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By 401(k) plan | shares_owned_after: 942.29 | Footnotes: F4

Footnotes:

• F1: The shares were purchased pursuant to a dividend reinvestment program offered through a brokerage account maintained by the reporting person.
• F2: Amount includes 144.6260 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report (the "DRSPP").
• F3: Amount includes 0.5921 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.
• F4: Amount includes 6.145 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.